Use of transglutaminases as immunosuppressants

US5464615A · kind A · utility

Assignee

• Behringwerke Aktiengesellschaft · DE

Inventors

• Thomas Stief · Linden, DE
• Norbert Heimburger
• Hans-Ulrich Schorlemmer · Marburg, DE

Key dates

• Filing date: Sep 22, 1994
• Grant date: Nov 7, 1995
• Expiry date: Sep 22, 2014

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N9/1044
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A description is given of the possibility of using transglutaminases in a process for the preparation of an immunosuppressant. Additionally described is a pharmaceutical containing a transglutaminase and a plasminogen activator inhibitor.